Aeterna Wealth

Mutual funds holding Glaxosmithkline Pharmaceuticals shares

74 mutual fund schemes held Glaxosmithkline Pharmaceuticals shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹2,163 cr in all. The largest holders by value are Kotak Large & Mid Cap Fund (1.0% of the fund), SBI Midcap Fund (1.3% of the fund), Nippon India Pharma Fund (2.8% of the fund).

Against the month before, 0 schemes added Glaxosmithkline Pharmaceuticals as a new holding and 5 sold out of it completely.

Sold out: Motilal Oswal BSE 1000 Index Fund, HDFC BSE 500 Index Fund, Motilal Oswal Nifty 500 Index Fund, SBI Nifty 500 Index Fund, DSP Nifty 500 Index Fund

By category: Index Fund (31), Sectoral/Thematic (15), Mid Cap (6), Multi Cap (4), Large & Mid Cap (3), Flexi Cap (3).

4 actively managed schemes holding it are rated A+ or A on their track record, among them Bajaj Finserv Flexi Cap Fund, Mahindra Manulife Small Cap Fund, Quant ELSS Tax Saver Fund, Aditya Birla Sun Life Multi-Cap Fund.

Every scheme holding Glaxosmithkline Pharmaceuticals, by value

SchemeRating% of fundValueChange
Kotak Large & Mid Cap FundLarge & Mid CapB1.00%₹302 cr–
SBI Midcap FundMid CapC1.32%₹294 cr-0.08
Nippon India Pharma FundSectoral/ThematicC2.83%₹257 cr-0.28
Quant Mid Cap FundMid CapC2.97%₹223 cr-0.25
Nippon India Growth Mid Cap FundMid CapB0.29%₹142 cr-0.02
SBI Dividend Yield FundDividend YieldB1.44%₹112 cr-0.11
Bajaj Finserv Flexi Cap FundFlexi CapA1.09%₹96 cr–
Mahindra Manulife Small Cap FundSmall CapA+1.13%₹59 cr–
Nippon India Multi Cap FundMulti CapB0.09%₹47 cr+0.03
Aditya Birla Sun Life MNC FundSectoral/ThematicC1.57%₹45 cr–
Quant ELSS Tax Saver FundELSSA0.34%₹44 cr-0.03
Bajaj Finserv Multi Cap FundMulti Cap–2.65%₹43 cr–
Helios Mid Cap FundMid Cap–1.73%₹42 cr-0.26
Baroda BNP Paribas Mid Cap FundMid CapB1.56%₹38 cr-0.13
quant Healthcare FundSectoral/ThematicB8.89%₹37 cr-0.80
Tata Business Cycle FundSectoral/ThematicC1.52%₹35 cr–
Aditya Birla Sun Life Multi-Cap FundMulti CapA0.38%₹27 cr–
Kotak Manufacture in India FundSectoral/ThematicB0.88%₹26 cr–
Bajaj Finserv Large & Mid Cap FundLarge & Mid Cap–1.06%₹24 cr–
Quant Multi Cap FundMulti CapC0.32%₹23 cr-0.02
quant Dynamic Asset Allocation FundBalanced AdvantageC2.61%₹21 cr–
Helios Small Cap FundSmall Cap–1.08%₹20 cr-0.13
Helios Large & Mid Cap FundLarge & Mid Cap–1.21%₹18 cr-0.16
Union Flexi Cap FundFlexi CapB0.66%₹15 cr–
Baroda BNP Paribas Dividend Yield FundDividend Yield–2.83%₹15 cr-0.45
DSP Quant FundSectoral/ThematicC1.88%₹13 cr-0.17
Kotak ESG Exclusionary Strategy FundSectoral/ThematicB1.82%₹12 cr–
SBI Quant FundSectoral/Thematic–0.48%₹12 cr+0.09
ITI Mid Cap FundMid CapB0.86%₹12 cr–
Motilal Oswal Nifty Midcap 150 Index FundIndex FundB0.26%₹10 cr-0.02
DSP Nifty Midcap 150 Quality 50 Index FundIndex FundB2.35%₹9 cr-0.20
Aditya Birla Sun Life Pharma and Healthcare FundSectoral/ThematicC0.83%₹9 cr–
Mahindra Manulife ELSS Tax Saver FundELSSC0.91%₹7 cr–
Nippon India Nifty Midcap 150 Index FundIndex FundB0.27%₹7 cr-0.01
Bajaj Finserv Healthcare FundSectoral/Thematic–1.63%₹7 cr–
UTI Nifty Midcap 150 Quality 50 Index FundIndex FundA2.55%₹6 cr–
Union Multi Asset Allocation FundMulti Asset Allocation–0.55%₹5 cr–
Baroda BNP Paribas Services FundSectoral/Thematic–0.88%₹5 cr-0.09
Union Aggressive Hybrid FundAggressive HybridB0.65%₹5 cr–
Union Balanced Advantage FundBalanced AdvantageC0.33%₹4 cr–

And 34 more schemes with smaller holdings.

Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.

Common questions

How many mutual funds hold Glaxosmithkline Pharmaceuticals shares?

74 schemes held Glaxosmithkline Pharmaceuticals in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹2,163 cr in all.

Which mutual fund holds the most Glaxosmithkline Pharmaceuticals shares?

By value, Kotak Large & Mid Cap Fund: about ₹302 cr, 1.00% of the fund.

Where does this data come from?

From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.

This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.

Free portfolio review

Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.

Chat with us